Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Teraoka SN, Diep TA, Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, Bernstein JL; Women's Environment, Cancer, and Radiation Epidemiology Study Collaborative Group. Concannon P, et al. Cancer Res. 2008 Aug 15;68(16):6486-91. doi: 10.1158/0008-5472.CAN-08-0134. Cancer Res. 2008. PMID: 18701470 Free PMC article.
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, Mellemkjaer L, Boice JD Jr, Siniard A, Duggan D, Thomas DC; WECARE Study Collaborative Group; Concannon P. Teraoka SN, et al. Among authors: concannon p. Breast Cancer Res. 2011;13(6):R114. doi: 10.1186/bcr3057. Epub 2011 Nov 17. Breast Cancer Res. 2011. PMID: 22087758 Free PMC article.
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L, Tischkowitz M, Haile RW, Shen R, Malone KE, Woods M, Liang X, Morrow M, Bernstein JL; WECARE Study Collaborative Group. Reiner AS, et al. Among authors: concannon p. Breast Cancer Res. 2017 Jul 19;19(1):83. doi: 10.1186/s13058-017-0874-x. Breast Cancer Res. 2017. PMID: 28724391 Free PMC article.
Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
Reiner AS, Robson ME, Mellemkjær L, Tischkowitz M, John EM, Lynch CF, Brooks JD, Boice JD, Knight JA, Teraoka SN, Liang X, Woods M, Shen R, Shore RE, Stram DO, Thomas DC, Malone KE, Bernstein L, Riaz N, Woodward W, Powell S, Goldgar D, Concannon P; WECARE Study Collaborative Group; Bernstein JL. Reiner AS, et al. Among authors: concannon p. J Natl Cancer Inst. 2020 Dec 14;112(12):1275-1279. doi: 10.1093/jnci/djaa031. J Natl Cancer Inst. 2020. PMID: 32119081 Free PMC article.
Smoking, Radiation Therapy, and Contralateral Breast Cancer Risk in Young Women.
Reiner AS, Watt GP, John EM, Lynch CF, Brooks JD, Mellemkjær L, Boice JD, Knight JA, Concannon P, Smith SA, Liang X, Woods M, Shore R, Malone KE, Bernstein L; WECARE Study Collaborative Group; Bernstein JL. Reiner AS, et al. Among authors: concannon p. J Natl Cancer Inst. 2022 Apr 11;114(4):631-634. doi: 10.1093/jnci/djab047. J Natl Cancer Inst. 2022. PMID: 33779721 Free PMC article.
Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer.
Bernstein JL, Teraoka S, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P; WECARE Study Collaborative Group. Bernstein JL, et al. Among authors: concannon p. Hum Mutat. 2003 May;21(5):542-50. doi: 10.1002/humu.10206. Hum Mutat. 2003. PMID: 12673797
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.
Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD Jr, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Børresen-Dale AL, Concannon P, Thompson WD; WECARE study. Bernstein JL, et al. Among authors: concannon p. Breast Cancer Res. 2004;6(3):R199-214. doi: 10.1186/bcr771. Epub 2004 Mar 9. Breast Cancer Res. 2004. PMID: 15084244 Free PMC article.
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN, Törngren T, Diep A, Xue S, Bertelsen L, Liang X, Reiner AS, Capanu M, Malone KE; WECARE Collaborative Study Group. Reding KW, et al. Among authors: concannon p. Breast Cancer Res Treat. 2010 Sep;123(2):491-8. doi: 10.1007/s10549-010-0769-3. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135344 Free PMC article.
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice JD Jr, Lynch CF, Mellemkjaer L, Malone KE, Liang X; Wecare Study Collaborative Group; Haile RW, Concannon P, Bernstein JL. Brooks JD, et al. Among authors: concannon p. Hum Mutat. 2012 Jan;33(1):158-64. doi: 10.1002/humu.21604. Epub 2011 Sep 29. Hum Mutat. 2012. PMID: 21898661 Free PMC article.
382 results